Skip to content

Impact of Drains on Postoperative Nausea and Vomiting After Thyroid Surgery

Randomized Controlled Trial on the Impact of Postoperative Drainage on Nausea and Vomiting After Thyroid- and Parathyroid Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01679418
Acronym
PONTS
Enrollment
139
Registered
2012-09-06
Start date
2007-11-30
Completion date
2012-06-30
Last updated
2016-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Keywords

PONV, thyroid, surgery, nausea and vomiting, postoperative

Brief summary

Wound Drains after Thyroid- and Parathyroid Surgery Impact on Postoperative Nausea and Vomiting (PONV)

Detailed description

Postoperative nausea and vomiting (PONV) is common after thyroid surgery. Many patients describe PONV as more irritant in the postoperative course than the endured pain. Postoperative drains are put after thyroid surgery to early recognize bleeding and to collect wound secretion to avoid pressure on the trachea. Whether wound drains do impact on PONV is not known. Therefore, we tested the impact of wound drains on PONV after thyroid- and parathyroid surgery in a randomized controlled clinical trial.

Interventions

DEVICEPlacement of a wound drain post surgery (Redon; Medicoplast)

The wound drain, type Redon Drainage 3.0 mm in diameter

OTHERNo-drain after surgery

After surgery, no drain was put

Sponsors

Kantonsspital Liestal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* older than 18 years of age * informed consent * planed thyroid- or parathyroid resection * euthyreostatic preoperative condition

Exclusion criteria

* younger than 18 years of age * pregnancy * no informed consent * retrosternal struma * known postoperative nausea and vomiting prior to surgery * severe and life threatening systemic health issues

Design outcomes

Primary

MeasureTime frameDescription
Assessment of post-operative nausea using visual analogue scale (VAS)24 hours post surgeryThe development of postoperative nausea was determined using a standard visual analogue scale (VAS) with range of 0 to 10. 0 indicated no nausea, 10 indicated very severe nausea. The patients indicated their felt degree of nausea a number between 0 to 10.
Assessment of postoperative vomiting using visual analogue scale (VAS)24 hours post surgeryThe development of postoperative vomiting was determined using a standard Visual analogue scale (VAS) with range of 0 to 10. 0 indicated no nausea, 10 indicated very severe nausea. The patients indicated their felt degree of vomiting indicating a number between 0 to 10. The number of vomiting was counted within the first 48h post surgery

Secondary

MeasureTime frameDescription
Antiemetic therapy post surgery in patients with and without postoperative drainageafter 48 hoursIn the postoperative course, we counted the amount of anti-emetic interventions for patients post surgery over the first 48 hours. The givage of anti-emetic drugs was based on a prior determined protocol, that was strictly followed. The protocol was as follows for antiemetic drugs: First line Drug: Tropisetron 2 mg i.v. when patient is vomiting, max. twice a day. Second line therapy: Haloperidol 0.5 mg i.v. with a maximum of 3 mg every 24 hours, when first line therapy is not sufficient. The change to second line therapy is controlled by the study physician.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026